Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,690 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Danese S, Colombel JF, Lukas M, Gisbert JP, D'Haens G, Hayee B, Panaccione R, Kim HS, Reinisch W, Tyrrell H, Oh YS, Tole S, Chai A, Chamberlain-James K, Tang MT, Schreiber S; GARDENIA Study Group. Danese S, et al. Among authors: kim hs. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):118-127. doi: 10.1016/S2468-1253(21)00294-6. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798038 Free article. Clinical Trial.
Clinical differences in Clostridium difficile infection based on age: a multicenter study.
Kim HH, Kim YS, Han DS, Kim YH, Kim WH, Kim JS, Kim H, Kim HS, Park YS, Song HJ, Shin SJ, Yang SK, Ye BD, Eun CS, Lee KM, Lee SH, Jang BI, Jung SA, Cheon JH, Choi CH, Huh K; IBD Study Group of the Korean Association for the Study of Intestinal Diseases. Kim HH, et al. Among authors: kim yh, kim wh, kim h, kim js, kim ys, kim hs. Scand J Infect Dis. 2014 Jan;46(1):46-51. doi: 10.3109/00365548.2013.840918. Epub 2013 Oct 10. Scand J Infect Dis. 2014. PMID: 24106984
Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study.
Choi YJ, Lee DH, Choi MG, Lee SJ, Kim SK, Song GA, Rhee PL, Jung HY, Kang DH, Lee YC, Lee SH, Choi SC, Shim KN, Seol SY, Moon JS, Shin YW, Kim HS, Lee ST, Cho JW, Choi EK, Lee OY, Jang JS. Choi YJ, et al. Among authors: kim sk, kim hs. J Korean Med Sci. 2017 Nov;32(11):1807-1813. doi: 10.3346/jkms.2017.32.11.1807. J Korean Med Sci. 2017. PMID: 28960033 Free PMC article. Clinical Trial.
Risk Factors for Postoperative Recurrence in Korean Patients with Crohn's Disease.
Kim SB, Cheon JH, Park JJ, Kim ES, Jeon SW, Jung SA, Park DI, Lee CK, Im JP, Kim YS, Kim HS, Lee J, Eun CS, Lee JM, Jang BI, Seo GS. Kim SB, et al. Among authors: kim ys, kim hs, kim es. Gut Liver. 2020 May 15;14(3):331-337. doi: 10.5009/gnl19085. Gut Liver. 2020. PMID: 31550869 Free PMC article.
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study.
Kim GH, Lee HL, Joo MK, Park HJ, Jung SW, Lee OJ, Kim H, Chun HJ, Lee ST, Kim JW, Jeon HH, Chung IK, Kim HS, Lee DH, Kim KO, Lim YJ, Park SJ, Cho SJ, Kim BW, Ko KH, Jeon SW, Kim JG, Sung IK, Kim TN, Sung JK, Park JJ. Kim GH, et al. Among authors: kim h, kim ko, kim bw, kim tn, kim hs, kim jw, kim jg. Gut Liver. 2021 Nov 15;15(6):841-850. doi: 10.5009/gnl20338. Gut Liver. 2021. PMID: 33827990 Free PMC article. Clinical Trial.
Clinical Features and Long-term Prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study.
Hong SW, Ye BD, Cheon JH, Lee JH, Koo JS, Jang BI, Lee KM, Kim YS, Kim TO, Im JP, Song GA, Jung SA, Kim HS, Park DI, Kim HS, Huh KC, Kim YH, Cha JM, Seo GS, Choi CH, Song HJ, Baik GH, Kim JW, Shin SJ, Park YS, Lee CK, Lee J, Jung SH, Jung Y, Park SC, Joo YE, Jeen YT, Han DS, Yang SK, Kim HJ, Kim WH, Kim JS. Hong SW, et al. Among authors: kim yh, kim wh, kim hj, kim js, kim ys, kim to, kim hs, kim jw. Gut Liver. 2022 Nov 15;16(6):907-920. doi: 10.5009/gnl210299. Epub 2022 Mar 24. Gut Liver. 2022. PMID: 35321956 Free PMC article.
Changes in fecal metabolic and lipidomic features by anti-TNF treatment and prediction of clinical remission in patients with ulcerative colitis.
Kim SY, Shin SY, Park SJ, Im JP, Kim HJ, Lee KM, Kim JW, Jung SA, Lee J, Kang SB, Shin SJ, Kim ES, Kim YS, Kim TO, Kim HS, Park DI, Kim HK, Kim ES, Kim YH, Teng D, Kim JH, Kim W, Saeed M, Moon JM, Kim K, Choi CH, Choi HK. Kim SY, et al. Among authors: kim yh, kim hj, kim w, kim hk, kim ys, kim to, kim hs, kim jw, kim es, kim jh, kim k. Therap Adv Gastroenterol. 2023 May 2;16:17562848231168199. doi: 10.1177/17562848231168199. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37153496 Free PMC article.
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis.
Lee KN, Lee OY, Chun HJ, Kim JI, Kim SK, Lee SW, Park KS, Lee KL, Choi SC, Jang JY, Kim GH, Sung IK, Park MI, Kwon JG, Kim N, Kim JJ, Lee ST, Kim HS, Kim KB, Lee YC, Choi MG, Lee JS, Jung HY, Lee KJ, Kim JH, Chung H. Lee KN, et al. Among authors: kim ji, kim jj, kim gh, kim n, kim kb, kim sk, kim hs, kim jh. World J Gastroenterol. 2022 Nov 28;28(44):6294-6309. doi: 10.3748/wjg.v28.i44.6294. World J Gastroenterol. 2022. PMID: 36504556 Free PMC article. Clinical Trial.
15,690 results
You have reached the last available page of results. Please see the User Guide for more information.